| Transforming growth factor β superfamily signaling in development of colorectal cancer B Jung, JJ Staudacher, D Beauchamp Gastroenterology 152 (1), 36-52, 2017 | 242 | 2017 |
| Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling J Bauer, MAB Emon, JJ Staudacher, AL Thomas, J Zessner-Spitzenberg, ... Scientific reports 10 (1), 50, 2020 | 122 | 2020 |
| NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway A Jana, NL Krett, G Guzman, A Khalid, O Ozden, JJ Staudacher, J Bauer, ... Oncotarget 8 (23), 37377, 2017 | 88 | 2017 |
| The predictors of mortality and secular changes in management strategies in emphysematous gastritis A Watson, V Bul, J Staudacher, R Carroll, C Yazici Clinics and Research in Hepatology and Gastroenterology 41 (1), e1-e7, 2017 | 72 | 2017 |
| Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer J Bauer, O Ozden, N Akagi, T Carroll, DR Principe, JJ Staudacher, ... Molecular cancer 14, 1-14, 2015 | 70 | 2015 |
| Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer JJ Staudacher, J Bauer, A Jana, J Tian, T Carroll, G Mancinelli, Ö Özden, ... Scientific reports 7 (1), 5569, 2017 | 61 | 2017 |
| Hypoxia-induced gene expression results from selective mRNA partitioning to the endoplasmic reticulum JJ Staudacher, IS Naarmann-de Vries, SJ Ujvari, B Klinger, M Kasim, ... Nucleic acids research 43 (6), 3219-3236, 2015 | 47 | 2015 |
| Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation DR Principe, B DeCant, J Staudacher, D Vitello, RJ Mangan, EA Wayne, ... Oncotarget 8 (3), 3826, 2017 | 44 | 2017 |
| Increased Frequency ofKRASMutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer JJ Staudacher, C Yazici, V Bul, J Zeidan, A Khalid, Y Xia, N Krett, B Jung Clinical and Translational Gastroenterology 8 (10), e124, 2017 | 41 | 2017 |
| Expression of an oncogenic BARD1 splice variant impairs homologous recombination and predicts response to PARP-1 inhibitor therapy in colon cancer O Ozden, F Bishehsari, J Bauer, SH Park, A Jana, SH Baik, JC Sporn, ... Scientific reports 6 (1), 26273, 2016 | 30 | 2016 |
| Multiorgan failure predicts mortality in emphysematous pancreatitis: a case report and systematic analysis of the literature V Bul, C Yazici, JJ Staudacher, B Jung, BR Boulay Pancreas 46 (6), 825-830, 2017 | 21 | 2017 |
| Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia M Kasim, E Benko, A Winkelmann, R Mrowka, JJ Staudacher, PB Persson, ... Journal of Biological Chemistry 289 (39), 26973-26988, 2014 | 14 | 2014 |
| Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target JJ Staudacher, C Yazici, T Carroll, J Bauer, J Pang, N Krett, Y Xia, ... Scientific reports 7 (1), 12786, 2017 | 10 | 2017 |
| Erstmalige interdisziplinäre DKK-Programmplanung durch Zusammenschluss onkologischer Nachwuchsgruppen MA Mäurer, T Huber, NP Sommer, I Mäurer, L Lazaridis, R Bodensohn, ... Forum 37 (1), 19-23, 2022 | 9 | 2022 |
| Increased stiffness of the tumor microenvironment in colon cancer leads to an increase in activin and metastatic potential J Bauer, JJ Staudacher, G Mancinelli, N Krett, E Bashar, P Grippo, ... Cancer Research 78 (13_Supplement), 177-177, 2018 | 7 | 2018 |
| Author Correction: Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling J Bauer, MAB Emon, JJ Staudacher, AL Thomas, J Zessner-Spitzenberg, ... Scientific reports 10, 2020 | 6 | 2020 |
| Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU) M Mäurer, J Staudacher, R Meyer, I Mäurer, L Lazaridis, M Müther, ... Journal of Cancer Research and Clinical Oncology 149 (12), 10075-10084, 2023 | 5 | 2023 |
| Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas JJ Staudacher, A Arnold, AA Kühl, M Pötzsch, S Daum, M Winterfeld, ... BMC cancer 22 (1), 953, 2022 | 4 | 2022 |
| NFkB is essential for activin-induced colorectal cancer migration via upregulation of PI3K-MDM2 pathway. Oncotarget. 2017 A Jana, NL Krett, G Guzman, A Khalid, O Ozden, JJ Staudacher, J Bauer, ... | 4 | |
| Commentary: Activin and TGFβ use diverging mitogenic signaling in advanced colon cancer J Bauer, JJ Staudacher, NL Krett, B Jung Journal of rare diseases research & treatment 1 (1), 43, 2016 | 3 | 2016 |
Ozkan OzdenKafkas University; University of Illinois at Chicago在 kafkas.edu.tr 的电子邮件经过验证
